Holen Sie sich die Stockscreener-App
1.13
2.59%
-0.03
Handel nachbörslich:
1.13
Milestone Pharmaceuticals Inc Aktie (MIST) Neueste Nachrichten
Milestone Pharmaceuticals Inc (MIST) Cash Flow - TradingKey
Milestone Pharmaceuticals Inc (MIST) Dividends & Stock Splits: Historical Payouts and Event Timeline - TradingKey
MIST|Milestone Pharmaceuticals Inc|Price:1.160|Chg%:-0.040 - TradingKey
TradingKey - TradingKey
Milestone Pharmaceuticals (MIST) Declines 3.33% as Stock Tests Key Support at $1.10Median Line - dars.gov.et
Milestone Pharmaceuticals Inc. Revenue Breakdown – NASDAQ:MIST - TradingView
Milestone Pharmaceuticals Inc (MIST) Risk Assessment: Volatility, Financial Risk & Investment Risk - TradingKey
Milestone Pharmaceuticals (MIST) Q4 2024 earnings summary - Quartr
Price to book forward of Milestone Pharmaceuticals Inc. – NASDAQ:MIST - TradingView
Milestone Pharmaceuticals Inc (MIST) Institutional Confidence - TradingKey
Milestone Pharmaceuticals (MIST) Investor update Summary - Quartr
Heart Rhythm Society and Milestone Pharmaceuticals Partner to Expand SVT Patient Education Through UpBeat.org - AOL.com
Milestone Pharmaceuticals (MIST) Slips 2.3% as Shares Test Key Support LevelsBuy Signal Reports - DonanımHaber
Milestone lures six new employees with 288,000 options - Stock Titan
Milestone Pharmaceuticals Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - The Manila Times
Enterprise value to EBIT forward of Milestone Pharmaceuticals Inc. – NASDAQ:MIST - TradingView
Enterprise value to EBIT forward of Milestone Pharmaceuticals Inc. – BOATS:MIST - TradingView
Price to sales forward of Milestone Pharmaceuticals Inc. – NASDAQ:MIST - TradingView
Price to sales forward of Milestone Pharmaceuticals Inc. – BOATS:MIST - TradingView
Enterprise value to EBITDA forward of Milestone Pharmaceuticals Inc. – NASDAQ:MIST - TradingView
Enterprise value to revenue forward of Milestone Pharmaceuticals Inc. – BOATS:MIST - TradingView
Price to earnings forward of Milestone Pharmaceuticals Inc. – BOATS:MIST - TradingView
Milestone Pharmaceuticals, Inc. Actuals & Estimates (NASDAQ:MIST) - TradingView
MIST Forecast — Price Target — Prediction for 2027 - TradingView
Phio Pharmaceuticals Reaches Key Milestone in Advancing Lead Candidate PH-762 - TMX Newsfile
Milestone Pharmaceuticals StockSunday background on the cardiac drug developer - AD HOC NEWS
Milestone Pharmaceuticals Inc (MIST) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
Milestone Pharmaceuticals Inc - TradingKey
Milestone Pharmaceuticals Inc (MIST) Technical Analysis: Support, Resistance, Indicators & Moving Averages - TradingKey
Milestone Pharmaceuticals Inc (MIST) Financial Health: Profitability & Balance Sheet Analysis - TradingKey
Milestone Pharmaceuticals Inc (MIST) Earnings Forecast: Future EPS & Revenue Growth Estimates - TradingKey
Milestone Pharmaceuticals Inc (MIST) Valuation: PE, PB & Fair Value Analysis - TradingKey
Milestone Pharmaceuticals (MIST) Climbs Over 5%: Biotech Stock Breaks Above Key Support ZoneDebt Free Companies - dars.gov.et
Milestone Pharmaceuticals Shareholders Approve Governance and Compensation Measures - The Globe and Mail
Milestone Pharmaceuticals Faces Financial Challenges amidst Market Shifts - timothysykes.com
Milestone Pharmaceuticals (MIST) investors approve equity plan, elect board and ratify PwC - Stock Titan
Milestone (NASDAQ: MIST) director receives 77,000 stock options grant - Stock Titan
Milestone Pharmaceuticals (MIST) director receives 77,000 stock options at $1.22 strike - Stock Titan
Milestone Pharmaceuticals (MIST) awards director 77,000 stock options - Stock Titan
Milestone Pharmaceuticals (MIST) director receives 77,000 stock options at $1.22 - Stock Titan
Director at Milestone Pharmaceuticals (MIST) receives 77,000 stock options at $1.22 - Stock Titan
Milestone Pharmaceuticals (NASDAQ: MIST) director receives 77,000 stock options grant - Stock Titan
Milestone Pharmaceuticals (MIST) director receives grant of 77,000 stock options - Stock Titan
Milestone Pharmaceuticals: Here Comes The Revenue Ramp (NASDAQ:MIST) - Seeking Alpha
Milestone Pharmaceuticals (MIST) Q1 2026 Earnings: Narrowing Losses as Clinical Progress ContinuesCost Structure Review - dars.gov.et
Novartis Canada and the pan-Canadian Pharmaceutical Alliance Achieve Milestone Agreement Enabling Public Reimbursement of (pr)Scemblix® (asciminib tablets) - Newswire Canada
Milestone Pharmaceuticals: Taking The Long View (NASDAQ:MIST) - Seeking Alpha
Eli Lilly scores a first in major pharma milestone - thestreet.com
Wockhardt's Zaynich wins US FDA approval, marking milestone in antibiotic innovation - Business Today
Milestone (MIST) Q1 2026 Earnings Transcript - The Globe and Mail
Milestone Pharmaceuticals Inc. Q1 2026 Earnings: Significant EPS Miss as Pre-Revenue Biotech Continues DevelopmentCFO Commentary Report - dars.gov.et
MISTMilestone Pharmaceuticals Inc Stock Price and Quote - Finviz
Anti-Aging Cell Therapy Reaches Major GMP Milestone as Wave of Clinical Advancements Gain Momentum - PR Newswire
Analysts Offer Insights on Healthcare Companies: Alpha Tau Medical Ltd (DRTS), Neurogene (NGNE) and Milestone Pharmaceuticals (MIST) - The Globe and Mail
[EFFECT] Milestone Pharmaceuticals Inc. SEC Filing - Stock Titan
H.C. Wainwright Maintains Milestone Pharmaceuticals(MIST.US) With Buy Rating, Maintains Target Price $8 - Moomoo
Milestone Pharmaceuticals (MIST) Slides 7.24% as Selling Pressure Builds—Key Support at $1.34 in FocusOBV Divergence - thelegaladvocate.com
Milestone Pharmaceuticals Q1 2026 Earnings: Clinical-Stage Biotech Reports Wider Loss Than ExpectedEPS Growth Rate - dars.gov.et
Milestone Pharmaceuticals Q1 earnings call highlights - MSN
MIST Stock Price, Quote & Chart | MILESTONE PHARMACEUTICALS IN (NASDAQ:MIST) - ChartMill
Supernus Pharmaceuticals to make $33.4 million CVR milestone payment - Investing.com
Milestone reports Q1 results, highlights initial CARDAMYST sales - MSN
1.97%
0.83%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):